NeoGenomics
NEO
100 hedge funds and large institutions have $220M invested in NeoGenomics in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 9 closing their positions.
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
9% more capital invested
Capital invested by funds: $202M → $220M (+$17.6M)
3% more funds holding
Funds holding: 97 → 100 (+3)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 34
Top Buyers
Top Sellers
NEO Hedge Fund Activity: Q3 2015 in Review
100 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2015, worth a combined $220M — up 8.7% from $202M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new NEO positions and 9 closed out — a net gain of 4 holders — while 34 added to existing stakes and 34 trimmed.
The largest buyer was Summit Creek Advisors, opening a new position worth an estimated $3.3M. The largest seller was THB Asset Management, cutting an estimated $5.32M.
- 100 institutional investors held NeoGenomics (NEO) as of Q3 2015, up from 97 in Q2 2015.
- Funds reported $220M of NeoGenomics stock for Q3 2015, up 8.7% quarter-over-quarter.
- 13 funds opened new NeoGenomics positions in Q3 2015 and 9 closed out, a net change of +4 holders.
- The largest NeoGenomics buyer in Q3 2015 was Summit Creek Advisors, an estimated $3.3M added.
- The largest NeoGenomics seller in Q3 2015 was THB Asset Management, an estimated $5.32M sold.
Based on aggregated 13F filings for Q3 2015.